TIMOTHY A. CLARY/AFP via Getty Images
Shares in Cassava Sciences plunged as much as 30% on Wednesday after a lawyer questioned the integrity of its experimental treatment for patients suffering with Alzheimer’s.
Comments regarding the “accuracy and integrity”…
